Papandreou MJ, Fenouillet E (1997). "Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation". FEBS Lett. 406 (1–2): 191–195. doi:10.1016/S0014-5793(97)00273-1. PMID9109416.
Bolmstedt A; Sjölander S; Hansen JE; et al. (1996). "Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (3): 213–220. doi:10.1097/00042560-199607000-00001. PMID8673525. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Yeh JC; Seals JR; Murphy CI; et al. (1993). "Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system". Biochemistry. 32 (41): 11087–11099. doi:10.1021/bi00092a019. PMID8218172. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Blough HA; Pauwels R; De Clercq E; et al. (1987). "Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins". Biochem. Biophys. Res. Commun. 141 (1): 33–38. doi:10.1016/S0006-291X(86)80330-8. PMID3099781. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Robinson WE, Montefiori DC, Mitchell WM (1988). "Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis". AIDS Res. Hum. Retroviruses. 3 (3): 265–282. doi:10.1089/aid.1987.3.265. PMID2829950.
Kozarsky K; Penman M; Basiripour L; et al. (1989). "Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein". J. Acquir. Immune Defic. Syndr. 2 (2): 163–169. PMID2649653. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)